Hematology 65th American Society of Hematology (ASH) Annual Meeting Dr. Tam & Dr. Johnson — Length: 06:58 Synergistic Approach: Promising Results of a Novel Combination Therapy for CLL/SLL Patients Watch Presentation
Hematology 65th American Society of Hematology (ASH) Annual Meeting Dr. Shadman & Dr. Hillis — Length: 08:18 Intolerance Trial: Differences in Adverse Events Among Second-generation BTK Inhibitors Watch Presentation
Hematology 65th American Society of Hematology (ASH) Annual Meeting Dr. Michelle N. Geddes — Length: 07:19 Clinical Advancements and Application of Erythroid Maturation Agents in the Treatment of MDS-related Anemia Watch Presentation
Dermatology Journées dermatologiques de Paris (JDP) 2023 Dr. Julien Ringuet — Length: 06:42 Long-term Insights and Practical Perspectives for Chronic Plaque Psoriasis Control Watch Presentation
Dermatology Journées dermatologiques de Paris (JDP) 2023 Dr. Dimitrios Kyritsis — Length: 05:30 DERMIS-1 & -2 Pooled Data: Novel Topical Treatment in Psoriasis Watch Presentation
Dermatology Journées dermatologiques de Paris (JDP) 2023 Dr. George Christodoulou — Length: 05:12 The STRATUM Study: Addressing Unmet Needs in Seborrheic Dermatitis Care Watch Presentation
Infectious Disease HIV: Expert Discussion Dr. Graham Smith & Dr. Mina Tadros — Length: 10:30 Patient-Driven HIV Therapy: A Collaborative Approach Watch Presentation
oncology Prostate Cancer: Expert Discussion Dr. Fred Saad & Dr. Michael Kolinsky — Length: 09:03 Strategies for Prolonging Survival: Treatment Intensification & PARP Inhibitors in mCRPC Watch Presentation
ophthalmology Retinal Conditions: Expert Interview Dr. David M. Brown — Length: 04:02 A Closer Look at Extended Treatment Intervals: PHOTON and PULSAR Studies Watch Presentation
Cardiology 15th World Stroke Congress 2023 Dr. Andrew Demchuk — Length: 07:26 Improved Bleeding Control with Specific Anti-FXa Reversal Agent: The ANNEXA-I Trial Watch Presentation
Cardiology 15th World Stroke Congress 2023 October 10-12, 2023 — Toronto, Ontario Reversal Agent for Factor Xa Inhibitors Mitigates Intracranial Bleeding in Phase 4 Trial Download 4 PowerPoint slides
neurology International Headache Congress 2023 September 14-17, 2023 — Seoul, Korea Sustained Suppression of Migraine Demonstrated in DELIVER Follow-up Now Exceeding 18 Months Download 3 PowerPoint slides
